ALLMedicine™ Vitiligo Center

Nov 24th, 2020 - The authors collected demographics and assessed the impact of vitiligo using Vitiligo Quality of Life (VitiQoL) and Vitiligo Impact Scale (VIS), followed by a focused survey and semistructured interviews with 22 participants in midwestern Nepal. V...

Nov 21st, 2020 - Vitiligo is a common pigmentary skin disorder and genetic factors were acknowledged to be greatly associated with the pathogenesis of this disease. Recently, increasing studies investigated the associations of methylenetetrahydrofolate reductase (...

Nov 21st, 2020 - To compare efficacy of targeted broad-band UVB phototherapy and topical psoralen with targeted UVA phototherapy treatments in localized vitiligo for three months prospectively. The cases with symmetrical vitiligo lesions were included in the study...

Nov 20th, 2020 - Epidermal melanocytes are constantly exposed to environmental stressors such as ultraviolet light (UV) and chemotoxins. Several evolutionarily conversed survival mechanisms are deployed to ensure melanocyte recovery after damage including the unfo...

Nov 20th, 2020 - Pembrolizumab is an immune checkpoint inhibitor designed to block the interaction between programmed death-1 and programmed death-ligand 1 and 2. It shows efficacy in the treatment of patients with advanced non-small cell lung cancer, among others...

Feb 27th, 2013 - Vitiligo is an acquired pigment disorder in which depigmented macules result from the loss of melanocytes from the involved regions of skin and hair. The color dissimilarity on the cosmetically sensitive regions frequently induces quality of life ...

Aug 6th, 2012 - The aetiopathogenic mechanisms of vitiligo are still poorly understood, and this has held back progress in diagnosis and treatment. Up until now, treatment guidelines have existed at national levels, but no common European viewpoint has emerged. T...

Nov 27th, 2008 - This detailed and user-friendly guideline for the diagnosis and management of vitiligo in children and adults aims to give high quality clinical advice, based on the best available evidence and expert consensus, taking into account patient choice ...

Nov 24th, 2020 - The authors collected demographics and assessed the impact of vitiligo using Vitiligo Quality of Life (VitiQoL) and Vitiligo Impact Scale (VIS), followed by a focused survey and semistructured interviews with 22 participants in midwestern Nepal. V...

Nov 21st, 2020 - Vitiligo is a common pigmentary skin disorder and genetic factors were acknowledged to be greatly associated with the pathogenesis of this disease. Recently, increasing studies investigated the associations of methylenetetrahydrofolate reductase (...

Nov 21st, 2020 - To compare efficacy of targeted broad-band UVB phototherapy and topical psoralen with targeted UVA phototherapy treatments in localized vitiligo for three months prospectively. The cases with symmetrical vitiligo lesions were included in the study...

Nov 20th, 2020 - Epidermal melanocytes are constantly exposed to environmental stressors such as ultraviolet light (UV) and chemotoxins. Several evolutionarily conversed survival mechanisms are deployed to ensure melanocyte recovery after damage including the unfo...

Nov 20th, 2020 - Pembrolizumab is an immune checkpoint inhibitor designed to block the interaction between programmed death-1 and programmed death-ligand 1 and 2. It shows efficacy in the treatment of patients with advanced non-small cell lung cancer, among others...

Oct 8th, 2020 - Takeaway Combination treatment with hand-held narrowband-ultraviolet B (NB-UVB) light and potent topical corticosteroid (TCS) is likely to result in improved treatment response in patients with localised non-segmental vitiligo compared with potent...

Sep 20th, 2020 - NEW YORK (Reuters Health) - Vitiligo patients who receive long-term narrowband UVB phototherapy are at lower risk of major osteoporotic fractures, new research shows. "Systemic phototherapy to treat vitiligo can unexpectedly reduce the risk of fra...

Mar 19th, 2020 - Spillover to other diseases JAK inhibitors – some in oral and some in topical form – are showing efficacy in ongoing research for alopecia areata (AA) and vitiligo as well, Dr. Blauvelt said.

Feb 19th, 2020 - LAHAINA, HAWAII – Individuals with vitiligo demonstrated a markedly reduced rate of internal malignancies in a recent first-of-its-kind “big data” study from South Korea, Iltefat Hamzavi, MD, said at the Hawaii Dermatology Seminar provided by Glob.

Feb 5th, 2020 - To the Editor: Pembrolizumab is an anti–programmed death receptor 1 humanized monoclonal antibody used for treating advanced or metastatic melanoma. 1 It is associated with several immune-related adverse events because it blocks a T-cell receptor c.